BioRestorative Therapies Inc

NASDAQ:BRTX  
3.27
+0.32 (+10.84%)
Products, Regulatory

Biorestorative Therapies Announces Clinical Site Initiation For Co's Phase 2 Clinical Trial To Treat Chronic Lumbar Disc Disease

Published: 06/13/2022 11:36 GMT
BioRestorative Therapies Inc (BRTX) - Biorestorative Therapies Announces Clinical Site Initiation for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cldd).
Biorestorative Therapies Inc- Denver Spine and Pain Institute is First Clinical Site to Be Initiated.
Biorestorative Therapies Inc- Additional Selected Sites Are Expected to Be Initiated in 2022.